Found: 10
Select item for more details and to access through your institution.
High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor.
- Published in:
- Vaccines, 2022, v. 10, n. 2, p. 249, doi. 10.3390/vaccines10020249
- By:
- Publication type:
- Article
SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor.
- Published in:
- Vaccines, 2021, v. 9, n. 7, p. 706, doi. 10.3390/vaccines9070706
- By:
- Publication type:
- Article
Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 294, doi. 10.3390/vaccines8020294
- By:
- Publication type:
- Article
An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67570-0
- By:
- Publication type:
- Article
An inactivated SARS-CoV-2 vaccine based on a Vero cell culture-adapted high-titer virus confers cross-protection in small animals.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67570-0
- By:
- Publication type:
- Article
Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 9, p. 1970, doi. 10.3390/v15091970
- By:
- Publication type:
- Article
Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 10, p. 2082, doi. 10.3390/v13102082
- By:
- Publication type:
- Article
In vitro efficacy of artemisinin-based treatments against SARS-CoV-2.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93361-y
- By:
- Publication type:
- Article
Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-72328-5
- By:
- Publication type:
- Article
High density Huh7.5 cell hollow fiber bioreactor culture for high-yield production of hepatitis C virus and studies of antivirals.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-35010-5
- By:
- Publication type:
- Article